Skip to content

An Alternative Treatment for Parkinson’s Patients

An Alternative Treatment for Parkinson’s Patients

April is Parkinson’s Awareness Month and an opportune time to highlight the disease and how medical marijuana may be a beneficial treatment option for those living with the condition. Many Parkinson’s patients find themselves desperate for alternative treatment options that provide sufficient relief of their symptoms and help avoid or postpone the need for surgery down the road.

Understanding Parkinson’s

“Parkinson’s disease (PD) is a neurodegenerative disorder that affects predominantly dopamine-producing (“dopaminergic”) neurons in a specific area of the brain called the substantia nigra.” (parkinson.org). Symptoms of PD usually form over many years and the progression can vary from person to person. Some patients with PD may experience one or all of the following:

  • Tremors, mainly when resting
  • Bradykinesia, slow movements
  • Limb rigidity, stiffness of the arms or legs beyond general aging or arthritis
  • Gait and balance problems

In early signs of PD, patients may experience little to no expression on one side of the face, limited arm movement or soft or slurred speech. Overtime, the symptoms of Parkinson’s will increase. (mayoclinic.org) When diagnosing a patient with Parkinson’s, physicians will look at the patient’s medical history, review their signs and symptoms and conduct neurological and physical exams.  

Current Treatments of Parkinson’s

Unfortunately, the cause of PD remains unknown with no known cure. However, medications and surgery do help reduce the symptoms. Parkinson’s may not directly cause death in patients, but complications from the disease can be very serious. “The Centers for Disease Control and Prevention (CDC) rated complications from PD as the 14th cause of death in the United States.” (parkinson.org).

In addition to medications and possible surgeries, physicians may suggest various lifestyle changes for their patients to help improve quality of life. “In some cases, physical therapy that focuses on balance and stretching is also important. A speech-language pathologist may help improve speech problems.” (mayoclinic.org)

Treating with Medical Cannabis

Although the medications that physicians prescribe to their patients can be helpful, there still seems to be a gap in the efficacy of these medications. Patients with PD are often eager to find alternative methods to help subdue their symptoms, which leads many to look into the therapeutic capabilities of medical marijuana.

“Our bodies make natural cannabinoids that control sleep, appetite, mood and other processes by binding to receptors throughout the body and brain. These receptors are found in particularly high numbers in the basal ganglia, a circuit of brain cells that controls movement and is affected in Parkinson’s. Because the cannabinoids in marijuana bind to the receptors in our body and brain, researchers have looked at whether they could bind to basal ganglia and other receptors to modify the course of PD or help ease symptoms of disease.” – michealjfox.org

Despite the constant struggle to get medical marijuana into clinical trials, a handful have been conducted based on the effects medical cannabis has on decreasing motor/non-motor symptoms and levodopa-induced dyskinesia (involuntary movements that may result with long-term use of levodopa and many years of living with PD). Unfortunately, due to strict federal restrictions, there is insufficient evidence to definitively say that medical marijuana and cannabinoids are an effective treatment for Parkinson’s. However, it’s recognized that there could be substantial benefit to introducing the plant into a PD patient’s treatment plan if they’re the right fit.

Interested in treating your patients with medical marijuana, but worried you don’t currently have enough credible data to do so? Join Arfinn Med for FREE to get real medical marijuana treatment efficacies, discuss treatment options with other licensed physicians and stay up-to-date on all of the latest industry findings.

Sources: https://www.parkinson.org/Understanding-Parkinsons/What-is-Parkinsons/Young-Onset-Parkinsons

https://www.mayoclinic.org/diseases-conditions/parkinsons-disease/diagnosis-treatment/drc-20376062
https://www.apdaparkinson.org/article/medical-marijuana-and-parkinsons-disease/https://www.michaeljfox.org/foundation/news-detail.php?ask-the-md-medical-marijuana-and-parkinson-disease-a

Stories you may be interested in

New Feature: Calendar Integration

At Arfinn Med, we’re excited to announce the third feature update to join automated text messaging and note templating: calendar integration. With this addition, physicians can now integrate their Google Calendar or Calendy account. The implementation of calendar integration rounds out the Arfinn Med portal, making it a physician’s one-stop-shop EMR tool. How It Works…
Read More

Medical marijuana advocates concerned over recreational cannabis proposals

ALBUQUERQUE, N.M.— Some medical marijuana patients are concerned the proposed framework for legalizing recreational marijuana could have a potentially negative impact on the medical cannabis program. “It’s something that will devastate the medical program in doing so,” said Jason Barker, a medical cannabis advocate with Safe Access New Mexico. A special task force delivered a…
Read More

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More

Data Migration and Mapping Functions

Medical software does not have a good reputation for user experience and intuitive design. It can seem like a full-time job just learning how to use these software solutions.  In fact, according to a study from Stanford Medicine, 74% of doctors responded that their EMR increased the number of hours they work every day and…
Read More

COVID-19 and medical cannabis patients: What you need to know

In the midst of the COVID-19 maelstrom, the recent shuttering of nonessential stores has created concern around access to cannabis, particularly for medicinal cannabis consumers. Those who depend on cannabis for therapeutic purposes will be relieved to learn that across the US, medical cannabis dispensaries have been deemed essential services, comparable to pharmacies. As of March…
Read More

More Treatment Options, Better Patient Outcomes

As more states start to pass medical marijuana legislation, patients benefit from having more options available to them regarding their treatment.  In fact, a recent study from Columbia University’s Irving Medical Center found that, “States with active medical marijuana laws saw certain opioid prescription rates drop nearly 20 percent compared to states without medical marijuana…
Read More

Leave a Comment

You must be logged in to post a comment.